Interventional device developer Stentys has received CE Mark approval of its disconnectable and self-expanding stent platform for treatment of coronary artery bifurcations.

According to the Paris-based company, its self-expanding feature insures apposition in the initial hours and days after an acute MI procedure by being applied to the vessel surface during thrombus and vessel spasm relief, therefore avoiding malapposition. The disconnectability feature is designed to treat lesions close to a bifurcation.

Stentys said its platform is implanted by usual stenting techniques requiring no additional training.